#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Spinal cord injury cervical T-cell type acute leukaemia Chronic graft versus host disease in skin Stevens-Johnson syndrome Iron overload Leukocyte adhesion deficiency Neuronal ceroid lipofuscinosis Medulloblastoma recurrent Myotonic dystrophy Anti-myelin-associated glycoprotein associated polyneuropathy Epstein-Barr virus associated lymphoproliferative disorder Leiomyosarcoma recurrent Gastric cancer Acute myeloid leukaemia (in remission) Ewing's sarcoma More trials…

    Learn about Rare Diseases

    Nephroblastoma – Diagnostics Systemic sclerosis pulmonary Rhabdomyosarcoma recurrent Waldenstrom’s macroglobulinaemia – Treatment Shprintzen-Goldberg syndrome – Basic Information Turner’s syndrome Primary biliary cholangitis – Life with Disease Retinoblastoma – Trials in Disease Progressive multifocal leukoencephalopathy – Basic Information Primary biliary cholangitis – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Protein S Epinephrine C1 Esterase Inhibitor (Human) Lurasidone Human Serum Albumin 5% Ly4100511 Dorocubicel Aldesleukin Emiplacel Posaconazole Rgx-202 CHONDROITIN SULFATE SODIUM Annamycin Gskvx000000014593 ABBV-CLS-628 Gliquidone (-)-PHENSERINE TARTRATE Ranolazine Olanzapine Mitazalimab More therapies…

    Learn about Your Condition

    Fracture infection Sarcoma metastatic Perinatal depression Phaeochromocytoma Lipid metabolism disorder Chronic myeloid leukaemia Rasmussen encephalitis Respiratory failure Heparin resistance Abdominal wall pain Notalgia paraesthetica Diffuse large B-cell lymphoma Glycogen storage disorder Epileptic encephalopathy Liver transplant rejection More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • PET Imaging with [18F]AlF-FAPI-74 and Hyoscine Butylbromide in Patients Suspected of Endometriosis

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Endometriosis
    Investigated Drugs:
    • Hyoscine Butylbromide
    • [Al[18F]F]Fapi-74
    Belgium

  • Phase Ib/II Study of LP-184 in Patients with Advanced or Metastatic Urothelial Carcinoma

    Not yet recruiting

    1 1 1
    Investigated Diseases:
    • Transitional cell carcinoma
    Denmark

  • Preventing urinary tract infections in infants and children under 2 years with oral Escherichia coli strain Nissle 1917 probiotic: a randomized controlled trial

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Urinary tract infection
    Investigated Drugs:
    • Escherichia Coli Strain Nissle 1917
    Finland

  • Indapamide for Reducing Disability Progression in Adults with Primary and Secondary Progressive Multiple Sclerosis

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Multiple sclerosis
    Investigated Drugs:
    • INDAPAMIDE HEMIHYDRATE
    The Netherlands

  • Study of blinatumomab plus drug combination in children and adolescents with acute lymphoblastic leukemia

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute lymphocytic leukaemia
    Investigated Drugs:
    • Dexamethasone Acetate
    • Vinorelbine
    • Blinatumomab
    Germany

  • Reducing Toxicity of Dual PD‑1 and CTLA‑4 Checkpoint Therapy in Pleural Mesothelioma Patients with Ustekinumab (anti‑p40)

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Pleural mesothelioma
    Investigated Drugs:
    • Ustekinumab
    The Netherlands
Previous Page
1 … 680 681 682 683 684 … 1,656
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!